Comparable stake leader
Aztiq Pharma Partners S.a r.l.
SEC ownership of Alvotech
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001898416.
Disclosed value leader
Aztiq Pharma Partners S.a r.l.
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- ALVO, ALVOW on Nasdaq
- Parsed ownership sources
-
13D/G and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Aztiq Pharma Partners S.a r.l.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Aztiq Pharma Partners S.a r.l.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001898416
- Issuer location
- Luxembourg, Luxembourg
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Alvotech (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Aztiq Pharma Partners S.a...
Disclosed value leader
Aztiq Pharma Partners S.a...
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
Lead comparable stake: 33%
13D/G row: Aztiq Pharma Partners S.a r.l.
Showing 1-8 of 50 holder rows.
Quick read
Aztiq Pharma Partners S.a r.l. leads the comparable SEC ownership view at 33%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Aztiq Pharma Partners S.a r.l.'s linked filing trail.
Comparable ownership
Top 5
Aztiq Pharma Partners S.a r.l.
33%
Celtic Holdings SCA
28%
Rubric Capital Management LP
4%
MILLENNIUM MANAGEMENT LLC
1.1%
Bracebridge Capital, LLC
1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Aztiq Pharma Partners S.a r.l. |
13D/G
|
33%
|
$533,786,019
103,849,420 shares
|
$0 | 17 Dec 2025 |
| Celtic Holdings SCA |
13D/G
Celtic Holdings S.C.A.
|
28%
|
$367,482,379
107,450,988 shares
|
$0 | 26 Jun 2026 |
| Rubric Capital Management LP |
13F
Company
|
4%
|
$57,848,473
15,677,093 shares
|
— | 30 Jun 2026 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.1%
|
$15,732,846
4,263,644 shares
|
— | 30 Jun 2026 |
| Bracebridge Capital, LLC |
13F
Company
|
1%
|
$14,902,571
4,038,637 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.94%
|
$13,965,181
3,689,612 shares
|
— | 30 Jun 2026 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. |
13F
Company
|
0.73%
|
$10,552,201
2,859,675 shares
|
— | 30 Jun 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.44%
|
$6,376,328
1,728,002 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Recent insider transactions for Alvotech
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.